Drugs
FORT LEE, NJ: FORT LEE, NJ -- (Marketwire) -- 08/13/12 -- Grand Slam Asset Management, LLC writes open letter to the Taro Pharmaceutical Industries LTD. shareholders urging them to reject Sun Pharmaceutical Indust ...
WINNIPEG, MANITOBA: WINNIPEG, MANITOBA -- (Marketwire) -- 08/10/12 -- Miraculins Inc. (TSX VENTURE: MOM), a medical diagnostic company focused on acquiring, developing and commercializing diagnostic tests and risk asse ...
FOSTER CITY, CA: Continued Strong Revenue Growth for ZADAXIN(R), as Well as Primary Care and Oncology Product Lines ...
TALLAHASSEE, FL: FDA Announced New Regulation in Effort to Promote Egg Safety ...
TORONTO, ONTARIO: TORONTO, ONTARIO -- (Marketwire) -- 08/03/12 -- Gemoscan Canada, Inc. ("Gemoscan" or the "Corporation") (TSX VENTURE: GES) (MUN: 1GE) wishes to announce that it is offering up to ...
DUBLIN, IRELAND: DUBLIN, IRELAND -- (Marketwire) -- 08/02/12 -- Druggability Technologies Holdings Limited (DRGT), a privately held biotechnology platform company, today announced the appointment of Louis Scotti to ...
CARY, NC: CARY, NC -- (Marketwire) -- 08/02/12 -- Inc. (NASDAQ: CRTX) today announced that it will host a conference call at 8:30 a.m. ET on Thursday, August 9, 2012, to discuss its financial results for the ...
TORONTO, ONTARIO: The makers of REACTINE(R) release first-ever coast-to-coast audit of urban allergy landscape ...
FOSTER CITY, CA: FOSTER CITY, CA -- (Marketwire) -- 08/01/12 -- SciClone Pharmaceuticals, Inc. (NASDAQ: SCLN) today announced that it plans to report second quarter 2012 financial results on Wednesday, August 8, 2012 ...
PALATINE, IL: Company's Q2'12 Financial Results Release Rescheduled for Monday, July 30 ...
CONSHOHOCKEN, PA: CONSHOHOCKEN, PA -- (Marketwire) -- 07/26/12 -- NuPathe Inc. (NASDAQ: PATH), today announced that it has granted time-based stock options to Armando Anido, the Company's newly appointed chief ex ...
CONSHOHOCKEN, PA: CONSHOHOCKEN, PA -- (Marketwire) -- 07/25/12 -- NuPathe Inc. (NASDAQ: PATH), a biopharmaceutical company focused on the development and commercialization of branded therapeutics for diseases of the c ...
CAMBRIDGE, MA: Eteplirsen Treatment Results in Benefit of 69 Meters in 6-Minute Walk Test Over Placebo/Delayed Treatment Cohort; No Eteplirsen-Related Adverse Events Through Week 36 ...
LYON, FRANCE: LYON, FRANCE -- (Marketwire) -- 07/23/12 -- Flamel Technologies (NASDAQ: FLML) expects to release certain financial results for the second quarter of 2012, on Thursday, July 26th, before the market o ...
GAINESVILLE, FL: Further Expands NIMBUS' International Intellectual Property Protection ...
BELFAST, UNITED KINGDOM: Enhanced Interactive Content, Videos and Blog Showcase Diaceutics Expertise in Personalized Medicine ...
TORONTO, ONTARIO: TORONTO, ONTARIO -- (Marketwire) -- 07/18/12 -- Soricimed Biopharma Inc., a private company developing novel cancer therapeutics and diagnostics, is collaborating with Mount Allison University to de ...
CONSHOHOCKEN, PA: CONSHOHOCKEN, PA -- (Marketwire) -- 07/16/12 -- NuPathe Inc. (NASDAQ: PATH), a biopharmaceutical company focused on the development and commercialization of branded therapeutics for diseases of the c ...
